Toll-like receptor-4 signaling drives persistent fibroblast activation and prevents fibrosis resolution in scleroderma
Significance: This review provides current overview of the emerging role of innate immunity in driving fibrosis, and preventing its resolution, in scleroderma (systemic sclerosis, SSc). Understanding the mechanisms of dysregulated innate immunity in fibrosis and SSc will provide opportunities for th...
Main Authors: | Bhattacharyya, S, Midwood, K, Yin, H, Varga, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Mary Ann Liebert, Inc.
2017
|
פריטים דומים
-
Targeting Toll-like receptors in autoimmunity.
מאת: Midwood, K, et al.
יצא לאור: (2009) -
Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis.
מאת: Monaco, C, et al.
יצא לאור: (2011) -
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
מאת: Swati Bhattacharyya, et al.
יצא לאור: (2018-10-01) -
Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
מאת: Goh, F, et al.
יצא לאור: (2012) -
Toll-Like Receptor Signaling and Liver Fibrosis
מאת: Tomonori Aoyama, et al.
יצא לאור: (2010-01-01)